A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions

NCT03876106 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

EGFR Inhibitor Induced Acneiform Lesions

Interventions

DRUG: LUT014

Sponsor

Lutris Pharma Ltd.